BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35387681)

  • 1. THC labeling on cannabis products: an experimental study of approaches for labeling THC servings on cannabis edibles.
    Goodman S; Hammond D
    J Cannabis Res; 2022 Apr; 4(1):17. PubMed ID: 35387681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does Unit-Dose Packaging Influence Understanding of Serving Size Information for Cannabis Edibles?
    Goodman S; Hammond D
    J Stud Alcohol Drugs; 2020 Mar; 81(2):173-179. PubMed ID: 32359046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How four U.S. states are regulating recreational marijuana edibles.
    Gourdet C; Giombi KC; Kosa K; Wiley J; Cates S
    Int J Drug Policy; 2017 May; 43():83-90. PubMed ID: 28343113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis labelling and consumer understanding of THC levels and serving sizes.
    Leos-Toro C; Fong GT; Meyer SB; Hammond D
    Drug Alcohol Depend; 2020 Mar; 208():107843. PubMed ID: 32044091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Form and content of Jamaican cannabis edibles.
    Lindsay CM; Abel WD; Jones-Edwards EE; Brown PD; Bernard KK; Taylor TT
    J Cannabis Res; 2021 Jul; 3(1):29. PubMed ID: 34243817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Communicating THC levels and 'dose' to consumers: Implications for product labelling and packaging of cannabis products in regulated markets.
    Hammond D
    Int J Drug Policy; 2021 May; 91():102509. PubMed ID: 31351756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis edibles packaging: Communicative objects in a growing market.
    Ventresca M; Elliott C
    Int J Drug Policy; 2022 May; 103():103645. PubMed ID: 35276401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copycat and lookalike edible cannabis product packaging in the United States.
    Ompad DC; Snyder KM; Sandh S; Hagen D; Collier KJ; Goldmann E; Goodman MS; Tan ASL
    Drug Alcohol Depend; 2022 Jun; 235():109409. PubMed ID: 35459519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring consumer preferences for cannabis edible products to support public health policy: A discrete choice experiment.
    Donnan J; Johnston K; Coombs M; Najafizada M; Bishop L
    PLoS One; 2024; 19(5):e0292336. PubMed ID: 38753807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consumer use and understanding of labelling information on edible marijuana products sold for recreational use in the states of Colorado and Washington.
    Kosa KM; Giombi KC; Rains CB; Cates SC
    Int J Drug Policy; 2017 May; 43():57-66. PubMed ID: 28222305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative analysis of laws on recreational cannabis edibles between Canada and the United States of America.
    Goundar P; Macaulay T; Szafron M
    Int J Drug Policy; 2021 Aug; 94():103191. PubMed ID: 33756442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tasty THC: Promises and Challenges of Cannabis Edibles.
    Barrus DG; Capogrossi KL; Cates SC; Gourdet CK; Peiper NC; Novak SP; Lefever TW; Wiley JL
    Methods Rep RTI Press; 2016 Nov; 2016():. PubMed ID: 28127591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of cannabis edibles on driving and blood THC.
    Zhao S; Brands B; Kaduri P; Wickens CM; Hasan OSM; Chen S; Le Foll B; Di Ciano P
    J Cannabis Res; 2024 May; 6(1):26. PubMed ID: 38822413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of plain packaging and health warnings on consumer appeal of cannabis products.
    Goodman S; Leos-Toro C; Hammond D
    Drug Alcohol Depend; 2019 Dec; 205():107633. PubMed ID: 31678837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of cannabis-infused edibles on public safety and regulation.
    Peralt A; Ke P; Castaneto MS
    J Forensic Sci; 2022 Nov; 67(6):2387-2393. PubMed ID: 36097671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impacts of packaging on preferences for cannabis edibles: A discrete choice experiment.
    Cooper M; Shi Y
    Int J Drug Policy; 2024 Jun; 128():104453. PubMed ID: 38796927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A naturalistic study of orally administered vs. inhaled legal market cannabis: cannabinoids exposure, intoxication, and impairment.
    Bidwell LC; Karoly HC; Torres MO; Master A; Bryan AD; Hutchison KE
    Psychopharmacology (Berl); 2022 Feb; 239(2):385-397. PubMed ID: 34708254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-reported THC content and associations with perceptions of feeling high among cannabis consumers.
    Lineham J; Wadsworth E; Hammond D
    Drug Alcohol Rev; 2023 Jul; 42(5):1142-1152. PubMed ID: 37062952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noticing of cannabis health warning labels in Canada and the US.
    Goodman S; Hammond D
    Health Promot Chronic Dis Prev Can; 2021; 41(7-8):201-210. PubMed ID: 34427418
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Krüger M; van Eeden T; Beswa D
    Plants (Basel); 2022 Dec; 11(23):. PubMed ID: 36501366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.